Literature DB >> 6349966

Drug-induced neurological disorders.

R J Lane, P A Routledge.   

Abstract

When a patient presents with a neurological or neuromuscular disorder, it is essential to consider drugs as a possible cause. Drugs can affect virtually any part of the neuraxis and the resulting disorders can usually be classified in terms of the anatomical site affected and the clinical presentation. In general, the signs and symptoms of drug-induced neurological disorders are virtually indistinguishable from those seen in naturally occurring disease but are usually reversible if diagnosed early enough. Cortical depression may produce coma, particularly in overdose cases, but a large number of drugs can also initiate seizures in susceptible individuals. The effects of drugs in the pathogenesis of headaches are certainly underestimated, and the eye, hearing and balance mechanisms can be severely damaged by certain drugs before symptoms prompt investigation. The long term effects of antipsychotic drugs on basal ganglia demand that these drugs are used only when absolutely essential and for as short a period as possible. Finally, there is increasing awareness of the role of drugs in the development of neuromuscular disorders such as peripheral neuropathies, myasthenic syndromes and myopathies.

Entities:  

Mesh:

Year:  1983        PMID: 6349966     DOI: 10.2165/00003495-198326020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  93 in total

1.  Chlorothiazide overdosage effects in two-year-old child.

Authors:  M E ROUGRAFF
Journal:  Pa Med J       Date:  1959-05

2.  Significance of oculocephalic and caloric responses in the unconscious patient.

Authors:  M NATHANSON; P S BERGMAN; P J ANDERSON
Journal:  Neurology       Date:  1957-12       Impact factor: 9.910

3.  Piperazine neurotoxicity: "worm wobble".

Authors:  A C Parsons
Journal:  Br Med J       Date:  1971-12-25

4.  Two cases of fatal salicylate poisoning after topical application of an antifungal solution.

Authors:  C P Lindsey
Journal:  Med J Aust       Date:  1968-03-02       Impact factor: 7.738

5.  Effects of penicillamine on the kidney and on taste.

Authors:  I A Jaffe
Journal:  Postgrad Med J       Date:  1968-10       Impact factor: 2.401

6.  Cimetidine-induced brainstem dysfunction.

Authors:  W J Cumming; J B Foster
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

7.  Electromyographic changes after nitrofurantoin (Furadantin) therapy in nonuremic patients.

Authors:  T Lindholm
Journal:  Neurology       Date:  1967-10       Impact factor: 9.910

8.  Amitriptyline-induced ophthalmoplegia.

Authors:  R H Spector; R Schnapper
Journal:  Neurology       Date:  1981-09       Impact factor: 9.910

9.  Adverse reactions to cromolyn.

Authors:  G A Settipane; D E Klein; G K Boyd; J H Sturam; H B Freye; J K Weltman
Journal:  JAMA       Date:  1979-02-23       Impact factor: 56.272

10.  Peripheral neuropathy in epileptic patients.

Authors:  T R Swift; J A Gross; L C Ward; B O Crout
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

View more
  4 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 2.  Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

3.  Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo.

Authors:  M B Allen; K Prowse
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

4.  Acute predominantly sensory neuropathy.

Authors:  K Sahashi; A Takahashi; T Ibi; S Gotoh; T Matsui
Journal:  Klin Wochenschr       Date:  1985-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.